fig1

Fast-tracking drug development with biomarkers and companion diagnostics

Figure 1. Ideal course of CDx Development includes initial steps of biomarker identification using varied modalities, analysis of biospecimens for biomarker level quantification leading to cancer indication finalization based on biomarker expression. These initial steps inform patient selection, companion diagnostic development and validation, and eventual large-scale treatment and follow-up for treatment efficacy.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/